Search Results - "Inno, Alessandro"

Long-Term Cardiovascular Toxicity of Immunotherapy: Too Important to Ignore.

Authors: Camerini, Andrea Inno, Alessandro Canale, Maria Laura et al.

Source: International Journal of Molecular Sciences. Sep2025, Vol. 26 Issue 18, p9100. 17p.

First-line tepotinib for a very elderly patient with metastatic NSCLC harboring MET exon 14 skipping mutation and high PD-L1 expression.

Authors: Inno, Alessandro Bogina, Giuseppe Settanni, Giulio et al.

Source: Drug Target Insights. Jan-Dec2023, Vol. 17 Issue 1, p110-113. 4p.

Deep Neural Network Integrated into Network-Based Stratification (D3NS): A Method to Uncover Cancer Subtypes from Somatic Mutations.

Authors: Valerio, Matteo Inno, Alessandro Zambelli, Alberto et al.

Source: Cancers. Aug2024, Vol. 16 Issue 16, p2845. 18p.

A New Era, New Risks: The Cardio-Oncology Perspective on Immunotherapy in Non-Small Cell Lung Cancer.

Authors: Tarantini, Luigi Gallucci, Giuseppina Inno, Alessandro et al.

Source: Cancers. Nov2025, Vol. 17 Issue 21, p3443. 32p.

PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway Inhibition.

Authors: Quagliariello, Vincenzo Berretta, Massimiliano Bisceglia, Irma et al.

Source: International Journal of Molecular Sciences. Jul2025, Vol. 26 Issue 14, p6617. 21p.

Activity of sotorasib against brain metastases from NSCLC harboring KRAS p.G12C mutation: a case report.

Authors: Inno, Alessandro Marchetti, Fabiana Valerio, Matteo et al.

Source: Drug Target Insights. Jan-Dec2023, Vol. 17 Issue 1, p90-91. 2p.

Anastrozole-related acute hepatitis with autoimmune features: a case report.

Authors: Inno, Alessandro Basso, Michele Vecchio, Fabio M. et al.

Source: BMC Gastroenterology. 2011, Vol. 11 Issue 1, p32-35. 4p.

Treatment Options for Advanced Non-Small Cell Lung Cancer After Failure of Previous Immune Checkpoint Inhibitors and Chemotherapy: Meta-Analysis of Five Randomized Controlled Trials.

Authors: Messori, Andrea Ossato, Andrea Gasperoni, Lorenzo et al.

Source: Current Oncology. Jan2025, Vol. 32 Issue 1, p46. 11p.

Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer Patients.

Authors: Quagliariello, Vincenzo Canale, Maria Laura Bisceglia, Irma et al.

Source: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11299. 16p.

Atherosclerosis and the Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside—Part 1.

Authors: Gallucci, Giuseppina Turazza, Fabio Maria Inno, Alessandro et al.

Source: International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 8, p4232. 25p.

The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients.

Authors: Quagliariello, Vincenzo Berretta, Massimiliano Bisceglia, Irma et al.

Source: Cancers. Apr2024, Vol. 16 Issue 8, p1487. 18p.

5-EPIFAT trial protocol: a multi-center, randomized, placebo-controlled trial of the efficacy of pharmacotherapy for fatigue using methylphenidate, bupropion, ginseng, and amantadine in advanced cancer patients on active treatment.

Authors: Miladinia, Mojtaba Jahangiri, Mina White, Sharon Jackson et al.

Source: Trials. 4/3/2024, Vol. 25 Issue 1, p1-12. 12p.

SGLT2 Inhibitors in Cancer Patients: A Comprehensive Review of Clinical, Biochemical, and Therapeutic Implications in Cardio-Oncology.

Authors: Greco, Alessandra Canale, Maria Laura Quagliariello, Vincenzo et al.

Source: International Journal of Molecular Sciences. May2025, Vol. 26 Issue 10, p4780. 22p.

In the Era of Cardiovascular–Kidney–Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and Therapy.

Authors: Quagliariello, Vincenzo Berretta, Massimiliano Bisceglia, Irma et al.

Source: Cancers. Apr2025, Vol. 17 Issue 7, p1169. 41p.

Exemestane induces liver toxicity in zebrafish larvae by upregulating the p53 signaling pathway.

Authors: Li W Zhou X Chen W et al.

Source: Fish physiology and biochemistry [Fish Physiol Biochem] 2025 Oct 20; Vol. 51 (6), pp. 177. Date of Electronic Publication: 2025 Oct 20.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 100955049 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-5168 (Electronic) Linking ISSN: 09201742 NLM ISO Abbreviation: Fish Physiol Biochem Subsets: MEDLINE

Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management.

Authors: Gallucci, Giuseppina Larocca, Mario Navazio, Alessandro et al.

Source: International Journal of Molecular Sciences. Jan2025, Vol. 26 Issue 1, p334. 29p.

PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology.

Authors: Quagliariello, Vincenzo Bisceglia, Irma Berretta, Massimiliano et al.

Source: Cancers. Mar2023, Vol. 15 Issue 5, p1397. 17p.

Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study.

Authors: Gori, Stefania Inno, Alessandro Rossi, Valentina et al.

Source: PLoS ONE. 5/25/2016, Vol. 11 Issue 5, p1-10. 10p.

The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.

Authors: Gori, Stefania Inno, Alessandro Fiorio, Elena et al.

Source: PLoS ONE. 9/4/2015, Vol. 10 Issue 9, p1-14. 14p.

Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.

Authors: Gori, Stefania Inno, Alessandro Fiorio, Elena et al.

Source: PLoS ONE. 9/25/2015, Vol. 10 Issue 9, p1-1. 1p.